Original: http://www.medicalook.com/reviews/Virorax.html


Virorax, which is commonly prescribed as Zovirax, is typically used to treat herpes. This includes genital herpes, shingles, herpes encephalitis, and herpes in people with compromised immune systems. Virorax is a member of the antiviral medication family of drugs.

Virorax is not appropriate for everyone. A thorough medical history should be assessed prior to prescribing this medication. Patients with a medical history which includes kidney disease, liver disease, current dialysis, brain disorders, nervous system disorders, breathing problems, or electrolyte imbalances may not be able to take Virorax or may require careful monitoring while undergoing treatment with this medication, depending on the severity of the patient's condition.

The American Food and Drug Administration rated Virorax as a pregnancy risk category B. This means that this medication is not expected to cause harm or birth defects to an unborn baby. Since herpes can be passed from a mother to child during birth, it is vital that pregnant women are treated for herpes. Virorax does pass into the mother's breast milk and may cause harm to a nursing baby. This medication should not be prescribed to women who are nursing.

There is a risk of some serious side effects associated with Virorax. If a patient is experiencing a serious side effect or an allergic reaction they should seek immediate emergency medical assistance. Serious side effects which require emergency medical treatment include fever, chills, body aches, flu symptoms, difficulty urinating, no urine output, a red, blistering, or peeling skin rash, skin edema or pain at the injection site, skin color changes at the injection site, confusion, agitation, tremors, jaundice, pale skin, easy bruising, unusual bleeding, weakness, fatigue, hallucinations, or convulsions. An allergic reaction will present symptoms which include facial skin edema, including skin edema of the lips, mouth, tongue, or throat, human immunodeficiency viruses, and difficulty breathing.

Less serious side effects typically do not require emergency medical treatment but should be reported to the prescribing physician. Patients should be encouraged to report all side effects to their doctor. Less serious side effects include headaches, lightheadedness, wamble, emesis, lack of appetite, diarrhea, stomach pain, skin edema in the hands or feet, muscle pain, numbness or tingling, insomnia or other sleep problems, and a lack of coordination. Less serious side effects can often be reduced to a tolerable level or even eliminated in some cases by reducing the dose of Virorax which is why it is important to discuss all side effects with your doctor.

Virorax should be taken exactly as prescribed by the physician. If a dose is missed, the dose should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped to avoid the potential for an overdose. The patient should never take a double dose of this medication. If an overdose is suspected, the patient should seek immediate emergency medical attention. An overdose will present with symptoms which include decreased peeing or no peeing, hallucinations, agitation, and seizures.

There is a risk of drug interactions associated with Virorax. Patients are urged to inquire with the prescribing physician before taking any new medicaments, including over the counter medicaments and herbal remedies. Medications with known negative interactions with Virorax include probenecid and some narcotic pain relievers.

Virorax has the following structural formula:

Chemical structure of virorax

• Molecular formula of virorax is C8H11N5O3
• Chemical IUPAC Name is 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one
• Molecular weight is 225.205 g/mol
Virorax available : 200mg capsules, 5% cream 2gm tube, 5% cream 5gm tube, 5% ointment 15gm tube, 200mg/5ml suspension 73ml bottle, 400mg tablets, 800mg tablets

©2007-2017 Medicalook.com All rights reserved